Clinical Trials Directory

Trials / Unknown

UnknownNCT05921877

AMH and Functional Hypothalamic Amenorrhea

AMH May Not be a Good Index of Ovarian Reserve in Patients With Functional Hypothalamic Amenorrhea

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
Female
Age
15 Years – 34 Years
Healthy volunteers

Summary

The purpose of this study is to analyze AMH levels in patients with prolonged FHA (more than 2 years). Based on previous studies, we can assume that prolonged FHA may mimic a condition of primary hypogonadotropic hypogonadism, due to a lasting interruption of gonadotropin release. Furthermore, after the resumption of the spontaneous menstrual cycle, we will reanalyze AMH levels, which we hypothesize to find higher. If our hypotheses are confirmed correct, we could support the thesis that AMH is not a good index of ovarian reserve in patients with functional hypothalamic amenorrhea.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTvenous samplingvenous sampling

Timeline

Start date
2023-06-16
Primary completion
2024-06-16
Completion
2024-12-31
First posted
2023-06-27
Last updated
2023-06-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05921877. Inclusion in this directory is not an endorsement.